Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GJ.1.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAGNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.4.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BK.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DJ.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.11.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EE.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2 (Omicron)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.66NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.6.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used